Extracorporeal Thrombogenesis: Mechanisms and Prevention

  • S. Fazal Mohammad


Blood-contacting prosthetic devices are playing an increasing role in the practice of medicine, and trends indicate that their use will continue to grow. Not only are hemodialyzers, blood oxygenators, and catheters used routinely, but the number of vascular grafts, heart valves, ventricular assist devices, and even total artificial hearts implanted in patients, grew steadily in the past decade. Through the use of these devices we have learned that thrombogenesis remains a potential problem when blood contacts an artificial surface (1, 2).


Thrombus Formation Polymer Surface Human Platelet Platelet Adhesion Biomed Mater 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Copley AL, Seaman GVF (editors): Surface Phenomena in Hemorheology: Their Theoretical, Experimental and Clinical Aspects New York, N Y Acad Sci, 1983Google Scholar
  2. 2.
    Salzman EW: Interaction of blood with artificial surfaces, in Hemostasis and Thrombosis, edited by Colman RW, Hirsh J, Marder VJ, Salzman EW, New York, Lippincott, 1987, p 1335Google Scholar
  3. 3.
    Forbes CD, Prentice CRM: Thrombus formation and artificial surfaces. Br Med Bull 34: 201, 1978PubMedGoogle Scholar
  4. 4.
    Lindsay RM, Mason RG, Kim SW, Andrade JD, Hakim RM: Blood surface interactions - report of ASAIO panel conference. Trans Am Soc Artif Intern Organs 26: 603, 1980PubMedGoogle Scholar
  5. 5.
    Merrill EW: Properties of material affecting the behavior of blood at their surface. Ann NY Acad Sci 283: 6, 1977Google Scholar
  6. 6.
    Andrade JD, Coleman DL, Van Wagoner R: Perspectives and future developments in the field of blood-materials interactions. in: Interactions of the Blood with Natural and Artificial Surfaces, edited by Salzman E, New York, Marcel Dekker, 1981, p 201Google Scholar
  7. 7.
    Andrade JD, Nagaoka S, Cooper S, Okano T, Kim SW: Surfaces and blood compatibility: current hypotheses, asaio J 10: 75, 1987Google Scholar
  8. 8.
    Mason RG, Chuang HYK, Mohammad SF, Saba HI: Thrombosis and artificial surfaces, in The Thromboembolic Disorders, edited by Van der Loo J, Prentice CRM, Beller FK, New York, Schattauer Verlag, 1983, p 533Google Scholar
  9. 9.
    Salzman EW, Merrill EW: Interaction of blood with artificial surfaces, in Hemostasis and Thrombosis, edited by Colman RW, Hirsh J, Marder VJ, Salzman EW, New York, Lippincott, 1982, p 931Google Scholar
  10. 10.
    Baier RE: Key events in blood interactions. Artif Organs 2: 422, 1978PubMedGoogle Scholar
  11. 11.
    Jackson CM, Nemerson Y: Blood Coagulation. Annu Rev Biochem 49: 765, 1980PubMedGoogle Scholar
  12. 12.
    Nemerson Y, Furie B: Zymogens and cofactors of blood coagulation. CRC Crit Rev Biochem 9: 45, 1980PubMedGoogle Scholar
  13. 13.
    Edmunds LH, Addonizio VP: Extracorporeal circulation, in Hemostasis and Thrombosis, edited by Colman RW, Hirsh J, Marder VJ, Salzman EW, New York, Lippincott, 1987, p 901Google Scholar
  14. 14.
    Jaques LB: 40 years of heparin research - past and future, in Heparin: Structure, Cellular Function and Clinical Applications, edited by McDuffie NM, New York, Academic Press, 1979, p 373Google Scholar
  15. 15.
    Kim SW, Ebert CD, Lin JY, McRea JC: Non-thrombogenic polymers: pharmaceutical approach, asaio J 6: 76, 1983Google Scholar
  16. 16.
    Heyman P, Cho C, McRea J, Kim SW: Heparinized polyurethanes: in-vitro and in-vivo studies. J Biomed Mat Res 19: 419, 1985Google Scholar
  17. 17.
    Mohammad SF, Anderson WH, Smith JB, Chuang HYK, Mason RG: Effects of heparin on platelet aggregation and release and thromboxane A2 production. Am J Pathol 104: 132, 1981PubMedGoogle Scholar
  18. 18.
    Salzman EW, Merrill EW, Binder A: Protein-platelet interaction on heparinized surfaces. J Biomed Mater Res 3: 69, 1969PubMedGoogle Scholar
  19. 19.
    Jacobs H, Okano T, Kim SW: Heparin-PGE1 conjugate releasing polymers. J Controlled Release 2: 313, 1985Google Scholar
  20. 20.
    Joint Committee for Stroke Resources: Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Stroke 8: 150, 1977Google Scholar
  21. 21.
    Anderson JM, Koftke-Merchant K: Platelet interactions with biomaterials. CRC Critical Reviews in Biocomposition 1: 111, 1985Google Scholar
  22. 22.
    Sawyer PN: Surface charge and thrombosis. Ann N Y Acad Sci 416: 561, 1984Google Scholar
  23. 23.
    Scarborough DE, Mason RG, Dalldorf FG: Morphologic manifestations of blood-solid interfacial reactions. Lab Invest 20: 164, 1969PubMedGoogle Scholar
  24. 24.
    Lee WH Jr, Krumhaar D, Fonkalsrud EW, Scheide OA, Maloney JV Jr: Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations. Surgery 56: 29, 1961Google Scholar
  25. 25.
    Wallace HW, Liquoir EM, Stein TP, Brooks H: Denaturated plasma and platelet function. Trans Am Soc Artif Intern Organs 21: 450, 1975PubMedGoogle Scholar
  26. 26.
    Nossel HL: Activation of factors XII and XI in thrombogenesis. Bull NY Acad Med 48: 281, 1972Google Scholar
  27. 27.
    Cochrane CG, Revak SD, Wuepper KD: Activation of Hageman factor in solid and fluid phases. J Exp Med 138: 1564, 1973PubMedGoogle Scholar
  28. 28.
    Schiffman S, Lee P: Partial purification and characterization of contact activation cofactor. J Clin Invest 56: 1082, 1975PubMedGoogle Scholar
  29. 29.
    Griffin JH, Cochrane CG: Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci USA 73: 2554, 1976PubMedGoogle Scholar
  30. 30.
    Cochrane CG, Wiggins RC, Revak SD: Activation of the contact system on a surface, in Hemostasis, Prostaglandins, and Renal Disease, edited by Remuzzi G, Mecca G, de Gaetano G, New York, Raven Press, 1980, p 125Google Scholar
  31. 31.
    Silverberg M, Dunn JT, Garen L, Kaplan AP: Autoactivation of human Hageman factor. J Biol Chem 255: 7281, 1980PubMedGoogle Scholar
  32. 32.
    Mannhalter C, Schiffman S: Surface adsorption of factor XI. Association of adsorption sites with the heavy chain of activated factor XI. Thromb Haemost 43: 124, 1980PubMedGoogle Scholar
  33. 33.
    Vroman L, Adams AL: Possible involvement of fibrogen and proteolysisin surface activation. Thromb Diath Haemorrh 18: 510, 1967PubMedGoogle Scholar
  34. 34.
    Vroman L, Adams AL, Klings M: Interactions among human blood proteins at interfaces. Fed Proc 30: 1494, 1971PubMedGoogle Scholar
  35. 35.
    Vroman L: What factors determine thrombogenicity? Bull NY Acad Med 48: 302, 1972Google Scholar
  36. 36.
    Vroman L, Adams AL, Fischer GC, Munoz PC: Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Fed Proc 30: 1494, 1971PubMedGoogle Scholar
  37. 37.
    Morrissey BW, Stromberg RR: The conformation of adsorbed blood proteins by infrared bound fraction measurements. J Colloid Interface Sci 56: 557, 1976Google Scholar
  38. 38.
    Morrissey BW, Stromberg RR: The conformation of adsorbed blood proteins by infrared bound fraction measurements. J Colloid Interface Sci 46: 152, 1976Google Scholar
  39. 39.
    Oja PD, Holmes GW: Specific coagulation factor adsorption as related to functional groups on surfaces. J Biomed Mater Res 3: 165, 1969PubMedGoogle Scholar
  40. 40.
    Lyman DJ, Brash JL, Chikin SW, Klein KG, Carini M: The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. II. Protein and platelet interaction on polymer surfaces. Trans Am Soc Artif Intern Organs 14: 250, 1968PubMedGoogle Scholar
  41. 41.
    Brash H, Lyman DJ: Adsorption of plasma proteins in solution to uncharged, hydrophobic polymer surfaces. J Biomed Mater Res 3: 175, 1969PubMedGoogle Scholar
  42. 42.
    Lyman DJ, Klein KG, Brash JL, Fritzinger BK: The interaction of platelets with polymer surfaces. I. Uncharged hydrophobic polymer surfaces. Thromb Diath Haemorrh 23: 120, 1970PubMedGoogle Scholar
  43. Brash JL, Lyman DJ: Adsorption of proteins and lipids to nonbiological surfaces, in The Chemistry of Biosurf aces, edited by Hair ML, New York, Marcel Dekker, 1971, vol 1, p 177Google Scholar
  44. 44.
    Friedman LI, Liem H, Grabowski EF, Leonard EF, McCord CW: Inconsequentially of surface properties for initial platelet adhesion. Trans Am Soc Artif Intern Organs 16: 63, 1970PubMedGoogle Scholar
  45. 45.
    Turitto VT, Leonard EF: Platelet adhesion to a spinning surface. Trans Am Soc Artif Organs 18: 348, 1972Google Scholar
  46. 46.
    Eberhart RC, Lynch ME, Bilge FH, Arts HA: Effects of fluid shear and temperature on protein adsorption on Teflon surfaces. Trans Am Soc Artif Intern Organs 26: 185, 1980PubMedGoogle Scholar
  47. 47.
    Lee RG, Kim SW: Adsorption of proteins onto hydrophobic polymer surfaces: Adsorption isotherms and kinetics. J Biomed Mater Res 8: 251, 1974PubMedGoogle Scholar
  48. 48.
    Lee RG, Adamson C, Kim SW, Lyman DJ: Determination of the surface energy of proteinated polymer surfaces. Thromb Res 3: 87, 1973Google Scholar
  49. 49.
    Waugh DF, Baughman DJ: Thrombin adsorption and possible relations to thrombus formation. J Biomed Mater Res 3: 145, 1969PubMedGoogle Scholar
  50. 50.
    Waugh DF, Lippe JA, Freund Y: Interaction of bovine thrombin and plasma albumin with low-energy surfaces. J Biomed Mat Res 12: 599, 1978Google Scholar
  51. 51.
    Chuang HYK, Sharma NC, Mohammad SF, Mason RG: Adsorption of thrombin onto artificial surfaces and its detection by an immunoradiometric assay. Artif Organs 3 (Suppl): 226, 1979Google Scholar
  52. 52.
    Chuang HYK, Mohammad SF, Sharma NC, Mason RG: Interaction of human a-thrombin with artificial surfaces and reactivity of adsorbed a-thrombin. J Biomed Mater Res 14: 467, 1980PubMedGoogle Scholar
  53. 53.
    Shuman MA, Tollefsen DM, Majerus PW: The binding of human and bovine thrombin to human platelets. Blood 47: 43, 1976PubMedGoogle Scholar
  54. 54.
    Mohammad SF, Whitworth C, Chuang HYK, Lundblad RL, Mason RG: Multiple active forms of thrombin-binding to platelets and effects on platelet function. Proc Natl Acad Sci USA 73: 1660, 1976Google Scholar
  55. 55.
    Didisheim P, Stropp JQ, Borowick JH, Grabowski AF: Species differences in platelet adhesion to biomaterials: investigation by a new two-stage technique, asaio J 2: 124, 1979Google Scholar
  56. 56.
    Schultz JS, Lindenauer SM, Penner J A, Barenberg S: Determinants of thrombus formation on surfaces. Trans Am Soc Artif Intern Organs 26: 279, 1980PubMedGoogle Scholar
  57. 57.
    Hanson SR, Harker LA, Ratner BD, Hoffman AS: In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombogenesis. J Lab Clin Med 95: 289, 1980PubMedGoogle Scholar
  58. 58.
    Salzman EW: Role of platelets in blood-surface interactions. Fed Proc 30: 1503, 1971PubMedGoogle Scholar
  59. 59.
    Salzman EW: Nonthrombeogenic surfaces: critical review. Blood 38: 509, 1971PubMedGoogle Scholar
  60. 60.
    Scarborough DE: The pathogenesis of thrombosis in artificial organs and vessels. Curr Top Pathol 54: 95, 1971Google Scholar
  61. 61.
    Salzman EW: Surface effects in hemostasis and thrombosis. in The Chemistry of Biosurfaces, edited by Hair ML, New York, Marcel Dekker, 1972, vol 2, p 489Google Scholar
  62. 62.
    Mohammad SF, Olsen DB: Reduced platelet adhesion and activation of coagulation factors on polyurethane treated with albumin-IgG complex. Trans Am Soc Artif Intern Organs 32: 323, 1986Google Scholar
  63. 63.
    Grevelink J, Wu F, Kolff WJ, Mohammad SF: Study of platelet function in a calf with artificial ventricles attached to an ex-vivo shunt. Trans Am Soc Artif Intern Organs 32: 177, 1986Google Scholar
  64. 64.
    Baier RE, DePalma VA, Furuse A, Gott VL, Lucas TY, Sawyer PN, Srinivasan S, Stanczweski B: Thrombo-resistance of glass cleaned by glow discharge treatment in argon. Abstracts Am Soc Artif Intern Organs 2: 3, 1973Google Scholar
  65. 65.
    Edmunds LH, Ellison N, Colman RW: Niewiarowski S, Rao AK, Addonizio VP, Stephenson LW, Edie RN: Platelet function during open heart surgery: Comparison to the membrane and bubble oxygenators. J Thor Cardiovasc Surg 83: 805, 1982Google Scholar
  66. 66.
    Salzman EW: Measurement of platelet adhesiveness. J Lab Clin Med 62: 724, 1963PubMedGoogle Scholar
  67. 67.
    Hope AF, Heyns A du P, Lotter MG, van Reenan OR, de Kock F, Badenhorst PN, Pieters H, Kotze H, Meyer JM, Minaar PC: Kinetics and sites of sequestration of indium111- labeled human platelets during cardiopulmonary bypass. J Thor Cardiovasc Surg 81: 880, 1981Google Scholar
  68. 68.
    Packham MA, Evans G, Glynn MF, Mustard JF: Effects of plasma proteins on interaction of platelets with glass surfaces. J Lab Clin Med 73: 686, 1969PubMedGoogle Scholar
  69. 69.
    Brash JL: Hydrophobic polymer surfaces and their interactions with blood. Ann N Y Acad Sci 283: 356, 1977Google Scholar
  70. 70.
    Andrade JD, Hlady V: Protein adsorption and material bio-compatibility. Adv Polymer Sci 19: 1, 1986Google Scholar
  71. 71.
    Andrade JD, Coleman JD, Didisheim P, Hanson SR, Mason RG, Merrill E: Blood-materials interactions: 20 years of frustration. Trans Am Soc Artif Intern Organs 21: 659, 1981Google Scholar
  72. 72.
    Colman RW: Surface-mediated defense reactions: the plasma contact activation system. J Clin Invest 73: 1249, 1984PubMedGoogle Scholar
  73. 73.
    Lyman DJ, Klein KG, Brash JJ, Fritzinger BK, Andrade JD, Bonomo FS: Platelet interaction with protein-coated surfaces: an approach to thrombo-resistant surfaces, in Platelet Adhesion and Aggregation in Thrombosis: Countermeasures, edited by Mammem EF, Anderson GF, Barnhard MI, Stuttgart FRG, FX Schattauer Verlag, 1970, p 109Google Scholar
  74. 74.
    Evans G, Mustard JF: Platelet-surface reaction and thrombosis. Surgery 64: 273, 1968PubMedGoogle Scholar
  75. 75.
    Zucker MB, Vroman L: Platelet adhesion induced by fibrinogen adsorbed onto glass. Proc Soc Exp Biol Med 131: 318, 1969PubMedGoogle Scholar
  76. 76.
    Mason RG, Shermer RW, Zucker WH: Effects of certain purified plasma proteins on the compatibility of glass with blood. Am J Pathol 73: 183, 1973PubMedGoogle Scholar
  77. 77.
    Sharma N, Mohammad SF, Chuang HYK, Mason RG: Inhibition of platelet adhesion to glass by certain human plasma and serum proteins, asaio J 3: 43, 1980Google Scholar
  78. 78.
    George JN: Direct assesment of platelet adhesion to glass: a study of the forces of interactions and the effects of plasma and serum factors, platelet function, and modification of the glass surface. Blood 40: 862, 1972PubMedGoogle Scholar
  79. 79.
    Mohammad SF, Hardison MD, Glenn CH, Morton BD, Bolan JC, Mason RG: Adhesion of human blood platelets to glass and polymer surfaces. I. Studies with platelets in plasma. Haemostasis 3: 257, 1974PubMedGoogle Scholar
  80. 80.
    Andrade JD, Kunitomo K, Van Wagenen R, Kastigir B, Gough D, Kolff WJ: Coated adsorbents for direct blood perfusion: hema/activated carbon. Trans Am Soc Artif Intern Organs 17: 222, 1971PubMedGoogle Scholar
  81. 81.
    Andrade JD: Interfacial phenomena and biomaterials. Med Instrum 1: 110, 1973Google Scholar
  82. 82.
    Mohammad SF, Hardison MD, Chuang HYK, Mason RG: Adhesion of human blood platelets to glass and polymer surfaces. II. Demonstration of the presence of natural platelet adhesion inhibitor in plasma and serum. Haemostasis 5: 96, 1976PubMedGoogle Scholar
  83. 83.
    Sharma NC, Mohammad SF, Chuang HYK, Mason RG: Isolation and some of the physiochemical and immunologic properties of a platelet adhesion inhibitor from human serum. Thromb Res 17: 683, 1980PubMedGoogle Scholar
  84. 84.
    Lee WH, Krumhaar D, Fonkalsrud E: Denaturation of plasma proteins as other cause of morbidity and death after intracardiac operations. Surgery 50: 29, 1961PubMedGoogle Scholar
  85. 85.
    Zapol WM, Levy RI, Kolobow T: In-vitro denaturation of plasma alpha lipoproteins in the dog. Curr Topic Surg Res 1: 449, 1969Google Scholar
  86. 86.
    Clark RE, Beauchamp RA, Magrath RA, Brooks JD, Ferguson TB, Weldon CS: Comparison of bubble and membrane oxygenators in short and long perfusions. J Thor Cardiovasc Surg 78: 655, 1979Google Scholar
  87. 87.
    Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW: Complement activation during cardiopulmonary bypass. N Engl J Med 304: 497, 1981PubMedGoogle Scholar
  88. 88.
    Boralessa H, Shifferli JA, Zaimi F, Watts E, Whitwam JG, Rees AJ: Perioperative changes in complement associated with cardiopulmonary bypass. Br J Anaesth 54: 1047, 1982PubMedGoogle Scholar
  89. 89.
    Leininger RI, Mirkovitch V, Beck RE, Andrus PG, Kolff WJ: The zeta potentials of some selected solids in respect to plasma and plasma fractions. Trans Am Soc Artif Intern Organs 10: 239, 1964Google Scholar
  90. 90.
    Baier RE, Gott VL, Feruse A: Surface chemical evaluation of thromboresistant materials before and after venous implantation. Trans Am Soc Artif Intern Organs 16: 50, 1970PubMedGoogle Scholar
  91. 91.
    Lee RG, Adamson C, Kim SW: Competetive adsorption of plasma proteins onto polymer surfaces. Thromb Res 4: 485, 1974PubMedGoogle Scholar
  92. 92.
    Kaelble DH, Moacanin J: A surface energy analysis of bioadhesion. Polymer 18: 475, 1977Google Scholar
  93. 93.
    Lee RG, Kim SW: The role of carbohydrate in platelet adhesion to foreign surfaces. J Biomed Mater Res 8: 393, 1974PubMedGoogle Scholar
  94. 94.
    Barber TA, Lambrecht LK, Mosher DL, Cooper SL: Influence of serum proteins on thrombosis and leukocyte adherence on polymer surfaces. Scan Electron Microsc 3: 881, 1979PubMedGoogle Scholar
  95. 95.
    Salzman EW, Merrill EW, Binder A, Wolf CFW, Ashford TP, Austen WG: Protein-platelet interaction on heparinized surfaces. J Biomed Mater Res 3: 69, 1969PubMedGoogle Scholar
  96. 96.
    Lindsay RM, Rourke J, Reid B, Friesen M, Linton AL, Courtney J, Gilchrist T: Platelets, foreign surfaces, and heparin. Trans Am Soc Artif Intern Organs 22: 292, 1976PubMedGoogle Scholar
  97. 97.
    Mason RG: The interaction of blood hemostatic elements with artificial surfaces. Prog Hemost Thromb 1: 141, 1972PubMedGoogle Scholar
  98. 98.
    Berger S, Salzman EW, Merrill EW, Wong PSL: The reaction of platelets with prosthetic surfaces, in Platelets: Production, Function, Transfusion and Storage, edited by Baldini MG, Ebbe S, New York, Grune and Stratton, 1974, p 299Google Scholar
  99. 99.
    Berger S, Salzman EW: Thromboembolic complications of prosthetic devices. Prog Hemost Thromb 2: 273, 1974PubMedGoogle Scholar
  100. 100.
    Mason RG, Mohammad SF, Chuang HYK, Richardson PD: The adhesion of platelets to subendothelium, collagen and artificial surfaces. Semin Thromb Hemostas 3: 98, 1976Google Scholar
  101. 101.
    Wethersby PK, Horbett TA, Hoffman AS: A new method for analysis of the adsorbed plasma protein layer on biomaterial surfaces. Trans Am Soc Artif Intern Organs 22: 242, 1976Google Scholar
  102. 102.
    Brown CH III, Lemuth RF, Heliums JD, Leverett LB, Alfrey CP: Response of human platelets to shear stress. Trans Am Soc Artif Intern Organs 21: 35, 1975PubMedGoogle Scholar
  103. 103.
    Brown CH III, Leverett LB, Lewis SW, Alfrey CP Jr, Heliums JD: Morphological, biochemical and functional changes in human platelets subjected to shear stress. J Lab Clin Med 86: 462, 1975PubMedGoogle Scholar
  104. 104.
    Johnston CG, Marzec U, Bernstein EF: Effects of surface injury and shear stress on platelet aggregation and serotonin release. Trans Am Soc Artif Intern Organs 21: 413, 1975PubMedGoogle Scholar
  105. 105.
    Roohk HV, Pick J, Hill R, Hung E, Bartlett RH: Kinetics of fibrinogen and platelet adherence to biomaterials. Trans Am Soc Artif Intern Organs 22: 1, 1976PubMedGoogle Scholar
  106. 106.
    Hung TC, Hochmuth RM, Joist JH, Sutera SP: Shear-induced aggregation and lysis of platelets. Trans Am Soc Artif Intern Organs 22: 285, 1976PubMedGoogle Scholar
  107. 107.
    Butruille YA, Leonard EF, Litwak RS: Platelet-platelet interactions and non-adhesive encounters on biomaterials. Trans Am Soc Artif Intern Organs 21: 609, 1975PubMedGoogle Scholar
  108. 108.
    Guidelines for blood-material interactions: Report of the National Heart, Lung and Blood Institute Working Group, NIH Publication No 85–2185, 1985, p 19Google Scholar
  109. 109.
    Whicher JS, Uniyal S, Brash JL: Platelet-foreign surface surface interactions: the release reaction from singly adherent platelets and adherent platelet aggregates. Trans Am Soc Artif Intern Organs 26: 268, 1980PubMedGoogle Scholar
  110. 110.
    Clagett GP, Russo M, Hufnagle H, Collins CJ Jr, Rich NM: Platelet serotonin changes in dogs with prosthetic aortic grafts. J Surg Res 28: 223, 1980PubMedGoogle Scholar
  111. 111.
    Malmgren R, Larson R, Olson P, Radegran K: Serotonin uptake and release by platelets adhering to polyethylene. Haemostasis 8: 400, 1979PubMedGoogle Scholar
  112. 112.
    Burch JW, Majerus PW: The role of prostaglandins in platelet function. Semin Hematol 16: 196, 1979PubMedGoogle Scholar
  113. 113.
    Chignard M, LeCouedic JP, Tence M, Vargaftig BB, Benveniste J: The role of platelet-activating factor in platelet aggregation. Nature 279: 799, 1979PubMedGoogle Scholar
  114. 114.
    Chap H, Mauco G, Simon MF, Benveniste J, Douste-Blazy L: Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. Nature 289: 312, 1981PubMedGoogle Scholar
  115. 115.
    Sharma NC, Mohammad SF, Chuang HYK, Mason RG: Isolation and physiochemical and immunologic characterization of human platelet factor 3. Thromb Res 16: 673, 1979PubMedGoogle Scholar
  116. 116.
    Sharma NC, Mohammad SF, Chuang HYK, Mason RG: Characterization of a platelet adhesion inhibitor from human serum and plasma as a complex of albumin with immunoglobulin G. Fed Proc 40: 810, 1981Google Scholar
  117. 117.
    Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoezzi E: Fibrinogen and ADP-induced platelet aggregation. Blood 52: 453, 1978PubMedGoogle Scholar
  118. 118.
    Marguerie GA, Plow EF, Edgington TS: Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 254: 5357, 1979PubMedGoogle Scholar
  119. 119.
    Tomikawa M, Iwamoto M, Soderman S, Blomback R: Effect of fibrinogen on ADP-induced platelet aggregation. Thromb Res 19: 841, 1980PubMedGoogle Scholar
  120. 120.
    Osterud B, Rapaport SI, Lavine KL: Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood 49: 819, 1977PubMedGoogle Scholar
  121. 121.
    Vicic WJ, Lages B, Weiss HJ: Release of human platelet factor V activity is induced by both collagen and ADP and is inhibited by aspirin. Blood 56: 448, 1980PubMedGoogle Scholar
  122. 122.
    Miletich JP, Jackson CM, Majerus PW: Properties of the factor Xa binding site on human platelets. Proc Natl Acad Sci USA 74: 4033, 1977PubMedGoogle Scholar
  123. 123.
    Miletich JP, Jackson CM, Majerus PW: Properties of the factor Xa binding site on human platelets. J Biol Chem 253: 6908, 1978PubMedGoogle Scholar
  124. 124.
    Lipcomb MS, Walsh PN: Human platelets and factor XI. Localization in platelet membranes of factor XI like activity and its functional distinction from plasma factor XI. J Clin Invest 63: 1006, 1977Google Scholar
  125. 125.
    Walsh PN, Griffin JH: Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 57: 106, 1981PubMedGoogle Scholar
  126. 126.
    Kaplan KL, Owen J: Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57: 199, 1981PubMedGoogle Scholar
  127. 127.
    Kaplan KL, Owen J: Radioimmunoassay of platelet factor 4. in Methods in Enzymology, Vol 70, edited by Vunakis HV, Langone JJ, New York, Academic Press, 1981, p 226Google Scholar
  128. 128.
    Hawiger J: Adhesive interactions of blood cells and the vessel wall, in Hemostasis and Thrombosis, edited by Colman RW, Hirsh J, Marder VJ, Salzman EW, New York, Lippincott, 1987, p 182Google Scholar
  129. 129.
    McGregor JL, Clemetson KJ, James E, Luscher EF, Dechavanne M: Characterization of human blood platelet membrane proteins and glycoproteins by their isoelectric point (pi) and apparent molecular weight using two-dimensional electrophoresis and surface-labelling techniques. Biochim Biophys Acta 599: 473, 1980PubMedGoogle Scholar
  130. 130.
    Ganguly P, Fossett NG: Inhibition of thrombin-induced platelet aggregation by a derivative of wheat germ agglutinin. Evidence for a physiologic receptor of thrombin in human platelets. Blood 57: 343, 1981PubMedGoogle Scholar
  131. 131.
    Hennessy VL Jr, Hicks RE, Niewiarowsky S, Edmunds LH Jr, Coleman RW: Function of human platelets during extracorporeal circulation. Am J Physiol 232: 4622, 1977Google Scholar
  132. 132.
    Clagett GP, Russo M, Hufnagel H: Platelet changes after placement of aortic prostheses in dogs. J Lab Clin Med 97: 345, 1981PubMedGoogle Scholar
  133. 133.
    Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha granule release. Blood 56: 824, 1980PubMedGoogle Scholar
  134. 134.
    Davies GC, Sobel M, Salzman EW: Elevated plasma fibrinopeptide A and thromboxane A2 levels during cardiopulmonary bypass. Circulation 61: 808, 1980PubMedGoogle Scholar
  135. 135.
    Harker LA, Marzec UM, Ginsberg MH: Thrombospondin levels in plasma, platelets and urine in normal subjects, subjects receiving heparin, thoracotomy patients and patients undergoing cardiopulmonary bypass. Thromb Haemost 50: 40, 1983Google Scholar
  136. 136.
    Lindsay RM, Prentice CRM, Davidson JF, Burton JA, McNicol GP: Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br Med J 2: 454, 1972Google Scholar
  137. 137.
    Kaplow JS, Goffinet JA: Profound neutropenia during the early phase of hemodialysis. JAMA 203: 1335, 1968Google Scholar
  138. 138.
    Toren M, Goffinet J A, Kaplow LS: Pulmonary bed sequestration of neutrophils during hemodialysis. Blood 36: 337, 1970PubMedGoogle Scholar
  139. 139.
    Jensen DP, Brubaker LH, Nolph KD, Johnson CA, Nothum RJ: Hemodialysis coil-induced transient neutropenia and overshoot neutrophilia in normal man. Blood 41: 399, 1973PubMedGoogle Scholar
  140. 140.
    O’Flaherty J, Craddock PR, Jacob US: Altered granulocyte adhesiveness (GA) during in vivo complement (C) activation. Blood 48: 987, 1976Google Scholar
  141. 141.
    Wauters JP, Lambert PH: Hemodialysis induced leukopenia: role of cellophane membrane and complement activation. Kidney Int (Abstract) 12: 77, 1977Google Scholar
  142. 142.
    Aljama P, Bird PAE, Ward MK, Feest TG, Walker W, Tanboga H, Sussman M, Kerr DNS: Haemodialysis-induced leukopenia and activation of complement: effects of different membranes. Proc Eur Dial Transplant Assoc 15: 144, 1978PubMedGoogle Scholar
  143. 143.
    Skubitz KM, Craddock PR: Reversal of hemodialysis granulocytopenia and pulmonary leukostasis. J Clin Invest 67: 1383, 1981PubMedGoogle Scholar
  144. 144.
    Zacharski LR, Mclntyre OR: Membrane-mediated synthesis of tissue factor (thromboplastin) in cultured fibroblasts. Blood 41: 679, 1973PubMedGoogle Scholar
  145. 145.
    Garg SK, Niemetz J: Tissue factor activity of normal leukemic cells. Blood 42: 729, 1973PubMedGoogle Scholar
  146. 146.
    Rickles FR, Hardin JA, Pitlick FA, Hoger LW, Conrad ME: Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A. J Clin Invest 52: 1427, 1973PubMedGoogle Scholar
  147. 147.
    Rapaport SI, Hjost PF: The blood clotting properties of rabbit peritoneal leukocytes in vitro. Thromb Diath Haemorrh 17: 222, 1967PubMedGoogle Scholar
  148. 148.
    Kociba GJ, Griesemer Ra: Disseminated intravascular coagulation induced with leukocyte procoagulant. Am J Pathol 69: 407, 1972PubMedGoogle Scholar
  149. 149.
    Saba HI, Herion JC, Walker RJ, Roberts HR: Effects of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis system. Thromb Res 7: 543, 1975PubMedGoogle Scholar
  150. 150.
    Niemetz J, Muhlfelder T, Chievego ME, Troy B: Procoagulant activity of leukocytes. Ann NY Acad Sci 283, 208, 1977Google Scholar
  151. 151.
    Camussi G, Mencia-Huerta JM, Benveniste J: Release of platelet activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology 33: 523, 1977PubMedGoogle Scholar
  152. 152.
    Morley J, Bray MA, Jones RW, Nugtenen DH, Van Dorp DA: Prostaglandin and thromboxane production by human and guinea-pig macrophages and leukocytes. Prostaglandins 17: 729, 1979PubMedGoogle Scholar
  153. 153.
    Beckman RS: Prostaglandin production by human blood monocytes and mouse peritoneal macrophages: synthesis dependent on in vivo culture conditions. Prostaglandins 21: 9, 1981Google Scholar
  154. 154.
    Dutton RC, Webber AJ, Johnson SA, Baier RE: Microstructure of initial thrombus formation on foreign materials. J Biomed Mater Res 3: 13, 1969PubMedGoogle Scholar
  155. 155.
    Baier RE, Dutton RC: Initial events in interactions of blood with a foreign surface. J Biomed Mater Res 3: 191, 1969PubMedGoogle Scholar
  156. 156.
    Ahearn DJ, Marshall JW, Nothum RJ, Esterly JA, Nolph KD, Mäher JF: Morphologic studies of dialysis membranes - adherence of blood components to air rinsed coils. Trans Am Soc Artif Intern Organs 19: 435, 1973PubMedGoogle Scholar
  157. 157.
    Mason RG, Wolf RH, Zucker WH, Shinoda BA: Dynamics of thrombus formation upon an artificial surface in vivo: effects of antithrombotic agents. Am J Pathol 82: 187, 1978Google Scholar
  158. 158.
    Mason RG, Zucker WH, Bilinsky RT, Shinoda BA, Mohammad SF: Blood components deposited on used and reused dialysis membranes. Biomater Med Devices Artif Organs 4: 333, 1976PubMedGoogle Scholar
  159. 159.
    Lindsay RM, Prentice CRM, Burton J A, Ferguson D, Kennedy AC: The role of the platelet-dialysis membrane interaction in thrombus formation and blood loss during hemodialysis. Trans Am Soc Artif Intern Organs 19: 487, 1973PubMedGoogle Scholar
  160. 160.
    Bjornson J, Kierulf P, Eika C, Godal HC: Fibrin deposits in the Kiil dialyzer. Scand J Haematol 1: 379, 1973Google Scholar
  161. 161.
    Marshall JW, Ahearn DJ, Nothum RJ, Esterly J, Nolph KD, Mäher JF: Adherence of blood components to dialyzer membranes. Morphological studies. Nephron 12: 157, 1974PubMedGoogle Scholar
  162. 162.
    Schwartz GH, Stenzel RH, Kohno I, Ast D, Miyata T, Rubin AL: Deposition of blood cells on collagen and Cuprophane membranes. J Biomed Mater Res 9: 453, 1975PubMedGoogle Scholar
  163. 163.
    Bilinsky RT, Morris AJ: Hemodialysis coil reuse. JAMA 218: 1806, 1971PubMedGoogle Scholar
  164. 164.
    Siemsen AW, Lumeng J, Wong EGC, Wong LMF, Ching A, Ennio JA, McGowan RF: Clinical laboratory evaluation of coil reuse. Trans Am Soc Artif Intern Organs 20: 585, 1974Google Scholar
  165. 165.
    Kramer P, Matthaei D, Go JG, Winckler K, SchielerF: Effect of blood factor deposits in reused dialysers on the dialysance of middle weight molecules. Proc Eur Dial Transplant Assoc 9: 278, 1972PubMedGoogle Scholar
  166. 166.
    George JN, Weed RI, Reed CF: Adhesion of human erythrocytes to glass: the nature of the interaction and the effect of serum and plasma. J Cell Physiol 77: 51, 1971PubMedGoogle Scholar
  167. 167.
    Hochmuth RM, Mohandas N, Spaeth EE, Williamson JR, Blackshear PL Jr, Johnson DW: Surface adhesion, deformation and detachment at low shear of red cells and white cells. Trans Am Soc Artif Intern Organs 18: 325, 1972PubMedGoogle Scholar
  168. 168.
    Goldsmith HL: The flow of model particles and blood cells and its relation to thrombogenesis. Prog Hemostas Thromb 1: 97, 1972Google Scholar
  169. 169.
    Goldsmith HL: The effects of flow and fluid mechanical stress on red cells and platelets. Trans Am Soc Artif Intern Organs 20: 21, 1974Google Scholar
  170. 170.
    Bartelt K, Forstrom R, Blackshear PL Jr: Blood platelet deposition onto filtering surfaces - effect of concentration polarization. Abstracts Am Soc Artif Intern Organs 5: 7, 1976Google Scholar
  171. 171.
    Forstrom RJ, Bartelt K, Blackshear PL Jr, Wood T: Formed element deposition onto filtering walls. Trans Am Soc Artif Intern Organs 21: 602, 1975PubMedGoogle Scholar
  172. 172.
    Wessler S, Gitel S: Control of heparin therapy. Prog Hemost Thromb 3: 311, 1976PubMedGoogle Scholar
  173. 173.
    Saba HI, Saba SR, Blackburn CA, Hartman RC, Mason RG: Heparin neutralization of PGI2: effects upon platelets. Science 205: 499, 1979PubMedGoogle Scholar
  174. 174.
    Charm S, Kurland GS: Viscometry of human blood for shear rates of 0–100, 000 sec−1. Nature 206: 617, 1965PubMedGoogle Scholar
  175. 175.
    Copley AL, Scott-Blair GW: Hemorheological method for the study of blood systems and of processes in blood coagulation. in Flow Properties of Blood, edited by Copley AL, Stainsby G, London, Pergamon Press, 1960, p 412Google Scholar
  176. 176.
    Rand PW, Lacombe E, Hunt HE, Austin WH: Viscosity of normal human blood under normothermic and hypothermic conditions. J Appl Physiol 19: 117, 1964PubMedGoogle Scholar
  177. 177.
    Peric B: Viscosity of the blood at low shear rates. Isr J Exp Med 11: 139, 1963Google Scholar
  178. 178.
    Blackshear PL Jr, Forstrom JR, Dorman FD, Voss GO: Effect of flow on cells near walls. Fed Proc 30: 1600, 1971PubMedGoogle Scholar
  179. 179.
    Goldsmith HL: Red cell motions and wall interactions in tube flow. Fed Proc 30: 1578, 1971PubMedGoogle Scholar
  180. 180.
    Grabowski EF, Friedman LI, Leonard EF: Effects of shear rates on the diffusion and adhesion of blood platelets to a foreign surface. Indust Eng Chem Fundam 11: 224, 1972Google Scholar
  181. 181.
    Nevaril CG, Lynch EC, Alfrey CP Jr, Heliums JD: Erythrocyte damage and destruction induced by shear stress. J Lab Clin Med 71: 784, 1968PubMedGoogle Scholar
  182. 182.
    Bernstein EF: Certain aspects of blood interfacial phenomena - red blood cells. Fed Proc 30: 1510, 1971PubMedGoogle Scholar
  183. 183.
    MacCallum RN, O’Bannon W, Heliums JD, Alfrey CP, Lynch EC: Viscometric instruments for studies on red blood cell damage, in Rheology of Biological Systems, edited by Gabelnick HL, Litt M, Springfield IL, Charles C Thomas, 1973, p 70Google Scholar
  184. 184.
    Solen KA, Whiffen JD, Lightfoot EN: The effect of shear, specific surface and air interface on the developments of blood emboli and hemolysis. J Biomed Mater Res 12: 381, 1978PubMedGoogle Scholar
  185. 185.
    Copley AL: Hemorheological aspects of the endothelium plasma interface. Microvasc Res 8: 192, 1974PubMedGoogle Scholar
  186. 186.
    Copley AL: Non-Newtonian behavior of surface layers of human plasma protein systems and a new concept of the initiation of thrombosis. Biorheology 10: 541, 1971Google Scholar
  187. 187.
    Hoffman AS: Blood-material interactions: An overview, in Biomaterials, Advances in Chemistry series no. 199, edited by Cooper SL, Peppas NA, Hoffman AS, Ratner BD, Am Chem Soc, Washington DC, 1982, p 3Google Scholar
  188. 188.
    Lindon J, Rosenberg R, Merrill E, Salzman E: Interaction of human platelets with heparinized agarose gel. J Lab Clin Med 91: 47, 1978PubMedGoogle Scholar
  189. 189.
    Anderson WH, Mohammad SF, Chuang HYK, Mason RG: Heparin potentiates synthesis of thromboxane A2 in human platelets. Adv Prostaglandin Thromboxane Res 6: 287, 1980PubMedGoogle Scholar
  190. 190.
    Mohammad SF, Anderson WH, Smith JB, Chuang HYK, Mason RG: Effects of heparin on platelet aggregation, release reaction and thromboxane A2 production. Am J Pathol 104: 132, 1981PubMedGoogle Scholar
  191. 191.
    Wurzinger LJ, Opitz R, Wolf M, Schmid-Schonbein H: Ultra-structural investigations on the question of mechanical activation of blood platelets. Blut 54: 97, 1987PubMedGoogle Scholar
  192. 192.
    Harker LA, Hirsh J, Gent M, Genton E: Critical evaluation of platelet inhibiting drugs in thrombotic disease. Prog Hematol 9: 229, 1975PubMedGoogle Scholar
  193. 193.
    Stewart JH, Farrell PC, Dixon M: Reduction of platelet and fibrin deposition in haemodialysers by aspirin administration. Aust NZ J Med 5: 117, 1975Google Scholar
  194. 194.
    Lindsay RM, Prentice CRM, Ferguson D, Burton JA, McNicol GP: Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 2: 1287, 1972PubMedGoogle Scholar
  195. 195.
    Sullivan JM, Harken DE, Gorlin R: Pharmacologic control of thromboembolic complications of cardiac valve replacement. N Eng J Med 284: 1391, 1971Google Scholar
  196. 196.
    Mielke CH, deLeval M, Hill JD, Macur MF, Gerbode F: Drug influence on platelet loss during extracorporeal circulation. J Thor Cardiovasc Surg 66: 845, 1973Google Scholar
  197. 197.
    Gurewich V, Lipinski B: Evaluation of antithrombotic properties of ‘Suloctodil’ in comparison with aspirin and dipyridamole. Thromb Res 9: 101, 1976PubMedGoogle Scholar
  198. 198.
    Gurewich V, Lipinski B, Wetmore R: Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals. Blood 45: 569, 1975PubMedGoogle Scholar
  199. 199.
    Harker LA, Slichter SJ: Studies of platelets and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med 293: 1302, 1970Google Scholar
  200. 200.
    Arrants JE, Hairston P, Lee WH Jr: Use of dipyridamole in preventing thromboembolism following valve replacement. Chest 58: 275, 1970Google Scholar
  201. 201.
    Welly HS, Genton E: Altered platelet function in patients with prosthetic mitral valves - effect of sulfinpyrazone therapy. Circulation 42: 967, 1970Google Scholar
  202. 202.
    Addonizio VP, Macarak EJ, Niewiarowski S, Colman RW, Edmunds LH: Preservation of human platelets with PGE1 during in vitro cardiopulmonary bypass. Trans Am Soc Artif Intern Organs 23: 639, 1977PubMedGoogle Scholar
  203. 203.
    Addonizio VP, Strauss JF, Macavak EJ, Colman RW, Edmunds LH: Preservation of platelet number with PGE1 during total cardiopulmonary bypass in rhesus monkeys. Surgery 83: 619, 1978PubMedGoogle Scholar
  204. 204.
    Mohammad SF, Mason RG, Eichwald EJ, Shively JA: Healthy and impaired vascular endothelium, in Blood platelet function and medicinal chemistry, edited by Lasslo L, New York, Alan R Liss, 1984, p 129Google Scholar
  205. 205.
    Coppe D, Wonders T, Snider M, Salzman EW: Preservation of platelet number and function during extracorporeal membrane oxygenation by regional infusion of prostacyclin, in Prostacyclin, edited by Vane JR, Bergstrom S, New York, Raven Press, 1979, p 385Google Scholar
  206. 206.
    Weston MJ, Woods HF, Ash G, Bunting S, Moncada S, Vane JR: Prostacyclin as an alternative to heparin in dogs, in Prostacyclin, edited by Vane JR, Bergstrom S, New York, Raven Press, 1979, p 349Google Scholar
  207. 207.
    Bunting S, Moncada S, Vane J, Woods HF, Weston MF: Prostacyclin improves hemocompatibility during charcoal hemoperfusion. in Prostacyclin, edited by Vane JR, Bergstrom S, New York, Raven Press, 1979, p 361Google Scholar
  208. 208.
    Harker LA: In vivo evaluation of antithrombin therapy in man. Thromb Diath Haemorrh 60 (suppl): 481, 1974Google Scholar
  209. 209.
    Didisheim P, Shimomoto T, Yamazaki H: Platelets, thrombosis and inhibitors. Thromb Diath Haemorrh 60 (suppl), 1974Google Scholar
  210. 210.
    Mason RG, Sargi K, Brinkhous KM: Antithrombotic agents - their effects on platelets and methods for their evaluation, in Cardiovascular Drugs, edited by McMahon FG, New York, Futura, 1974, p 183Google Scholar
  211. 211.
    Hirsh J, Cade JF, Gallus AS, Schonbaum E:Platelet, Drugs and Thrombosis New York, Basel, S Karger, 1975Google Scholar
  212. 212.
    Harker LA, Gent M: The use of agents that modify platelet function in the management of thrombotic disorders, in Haemostasis and Thrombosis, edited by Colman RW, Hirsh J, Marder VJ, Salzman EW, New York, Lippincott, 1987, p 1439Google Scholar
  213. 213.
    Gott VL: Wall-bound heparin - historical background and current clinical applications. Adv Exp Med Biol 52: 351, 1974Google Scholar
  214. 214.
    Leininger RI, Cooper CW, Epstein MM, Falb RD, Grode GA: Nonthrombogenic plastic surfaces. Science 152: 1625, 1966PubMedGoogle Scholar
  215. 215.
    Yen SPS, Rembaum A: Complexes of heparin with elastomeric positive polyelectrolytes. J Biomed Mater Res 1: 83, 1971Google Scholar
  216. 216.
    Merker RI, Elyash LJ, Mayhew SH, Wany JYC: The heparinization of silicone rubber using aminoorganosilane coupling agents, in Artificial Heart Program Conference, edited by Hagyeli RJ, National Heart Institute, Washington DC, 1969, p 29Google Scholar
  217. 217.
    Hufnagel CA, Conrad PW, Gillespie JF, Pifarre R, llano A, Yokoyama T: Comparative study of cardiac and vascular implants in relation to thrombosis. Surgery 61: 11, 1967PubMedGoogle Scholar
  218. 218.
    Grode GA, Anderson SJ, Crotte HM, Falb RD: Nonthrombogenic materials via a simple coating process. Trans Am Soc Artif Intern Organs 15: 1, 1969PubMedGoogle Scholar
  219. 219.
    Lagergren HR, Eriksson JC: Plastics with a stable surface monolayer of cross-linked heparin - preparation and evaluation. Trans Am Soc Artif Intern Organs 17: 10, 1971PubMedGoogle Scholar
  220. 220.
    Chawla AS, Chang TMS: Nonthrombogenic surface by radiation grafting of heparin - preparation, in vitro and in vivo studies. Biomater Med Devices Artif Organs 2: 157, 1974PubMedGoogle Scholar
  221. 221.
    Dycke MF: Inorganic heparin complexes for the preparation of nonthrombogenic surfaces. J Biomed Mater Res 6: 115, 1972Google Scholar
  222. 222.
    Martin RE, Shuey HF, Saltonstall GW Jr: Improved membranes for hemodialysis. J Macromol Sci Chem A 4: 635, 1970Google Scholar
  223. 223.
    Idezuki Y, Watanabe H, Hagiwara M, Kanasugi K, Mori Y, Nagaoka S, Hagio M, Yamamoto K, Tanjawa H: Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: Chronic in vivo studies and clinical application. Trans Am Soc Artif Intern Organs 21: 436, 1975PubMedGoogle Scholar
  224. 224.
    Eberle JW, Manton JR, Meals CR, Whitley DE, Rea WJ: Cross-linked heparin binding of a membrane oxygenator system. J Biomed Mater Res 1: 145, 1973Google Scholar
  225. 225.
    Leininger RI, Crowley JP, Falb RD, Grode GA: Three year’s, experience in vivo and in vitro with surfaces and devices tested by the heparin complex method. Trans Am Soc Artif Intern Organs 18: 312, 1972PubMedGoogle Scholar
  226. 226.
    Halpern BD, Shibakawa R: Heparin covalently bonded to polymer surface. Adv Chem Ser 87: 197, 1968Google Scholar
  227. 227.
    Merrill EW, Salzman EW, Wong PSL, Ashford TP, Brown AH, Austen WG: Polyvinyl alcohol-heparin hydrogel ‘G’J Appl Physiol 29: 723, 1970PubMedGoogle Scholar
  228. 228.
    Merrill EW, Salzman EW, Lipps BJ Jr, Gilliland ER, Austen WG, Joison E: Antithrombogenic cellulose membranes for blood dialysis. Trans Am Soc Artif Intern Organs 12: 139, 1966PubMedGoogle Scholar
  229. 229.
    Schmer G: The biological activity of covalently immobilized heparin. Trans Am Soc Artif Intern Organs 18: 321, 1972PubMedGoogle Scholar
  230. 230.
    Schmer G, Teng LNL, Cole JJ, Vizzo JE, Francisco MM, Scribner BH: Successful use of a totally heparin grafted hemodialysis system in sheep. Trans Am Soc Artif Intern Organs 22: 654, 1976PubMedGoogle Scholar
  231. 231.
    Hoffman AS, Schmer G, Harris C, Kraft WG: Covalent binding of biomolecules to radiation-grafted hydrogel on inert polymer surfaces. Trans Am Soc Artif Intern Organs 18: 10, 1972PubMedGoogle Scholar
  232. 232.
    Lansson R, Eriksson JC, Lagesgren H, Olsson P: Platelet and plasma coagulation compatibility of heparinized and sulphated surface. Thromb Res 15: 157, 1979Google Scholar
  233. 233.
    Falb RD, Leininger RI, Grode G, Crowley J: Surface-bound heparin. Adv Exp Med Biol 52: 365, 1974Google Scholar
  234. 234.
    Nader HG, McDuffe NM, Diettich CP: Heparin fractionation by electrofocusing. Presence of 21 components of different molecular weights. Biochem Biophys Res Commun 57: 488, 1974PubMedGoogle Scholar
  235. 235.
    Oosta GM, Gardner WT, Beeler DL, Rosenberg RD: Multiple functional domains of the heparin molecule. Proc Natl Acad Sci USA, 78, 829, 1981PubMedGoogle Scholar
  236. 236.
    Stewart GP, Wilkow MA: Mechanism of failure of biocompatible-treated surfaces. J Biomed Mater Res 10: 413, 1976PubMedGoogle Scholar
  237. 237.
    Falb RD, Takahashi MT, Grode GA, Leininger RI: Studies on the stability and protein adsorption characteristics of heparinized polymer surfaces by radioisotopic labeling techniques. J Biomed Mater Res 1: 239, 1967PubMedGoogle Scholar
  238. 238.
    Coleman DL, Atwood AI, Andrade JD: Platelet retention by albuminated glass and polystyrene beads. J Bioengineering 1: 33, 1976Google Scholar
  239. 239.
    Gentry PW, Alexander B: Specific coagulation factor adsorption to insoluble heparin. Biochem Biophys Res Commun 50: 500, 1973PubMedGoogle Scholar
  240. 240.
    Thaler E, Schmer G: A simple 2-step isolation procedure for human antithrombin II/III and its biological activity after insolubilization to agarose. Trans Am Soc Artif Intern Organs 20: 516, 1974PubMedGoogle Scholar
  241. 241.
    Chuang HYK, Crowther PE, Mohammad SF, Mason RG: Identification and quantitation of plasma proteins adsorbed to artificial surfaces by use of 125I-labeled specific antibodies. Fed Proc 37: 444, 1978Google Scholar
  242. 242.
    Chuang HYK, Mohammad SF, Sharma NC, Mason RG: Radioimmunoassays of human fibrinogen and alpha-thrombin adsorbed to artificial surfaces. Fed Proc 40: 806, 1981Google Scholar
  243. 243.
    Woods HF, Ash G, Weston MH, Bunting S, Moncada S, Vane JR: Prostacyclin can replace heparin in haemodialysis in dogs. Lancet 2: 1075, 1978PubMedGoogle Scholar
  244. 244.
    Turney JH, Woods HF, Weston MJ: The use of prostacyclin in extracorporeal circuits, in Hemostasis, Prostaglandins, and Renal Disease, edited by Remuzzi G, Mecca G, Gaetano G, New York, Raven Press, 1981, p 353Google Scholar
  245. 245.
    Grode GA, Putman J, Crowley, Leininger RI, Falb RD: Surface-immobilized prostaglandin as a platelet protective agent. Trans Am Soc Artif Intern Organs 20: 38, 1974Google Scholar
  246. 246.
    McRea JC, Kim SW: Characterization of controlled release of prostaglandin from polymer matrices for thrombus prevention. Trans Am Soc Artif Intern Organs 24: 746, 1978PubMedGoogle Scholar
  247. 247.
    Van Drup DA, Van Evert WC, Van der Wolf L: 20-methylprostacyclin, a powerful unnatural platelet aggregation inhibitor. Prostaglandins 16: 953, 1978Google Scholar
  248. 248.
    Dembinska-Kiec A, Rucker W, Schomhofer PS, Gandolf C: Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma. Thromb Haemost 42: 1340, 1979PubMedGoogle Scholar
  249. 249.
    Whittle BJR, Moncada S, Whiting F, Vane JR: Carbacyclin - a potent stable prostacyclin analogue for the inhibition of platelet aggregation. Prostaglandins 19: 605, 1980PubMedGoogle Scholar
  250. 250.
    Malmstem C, Claesson HE: Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13, 14-deydro PGI2 methyl ester. Prostaglandins Med 4: 453, 1980Google Scholar
  251. 251.
    Imai Y, Tajima K, Nose Y: Biolized materials for cardiovascular prosthesis. Trans Am Soc Artif Intern Organs 17: 6, 1971PubMedGoogle Scholar
  252. 252.
    Harasaki H, Kiraly R, Murabayashi S, Pepoy M, Fields A, Kambic H, Hillegass D, Nose Y: Cross-linked gelatin as blood contacting surface. Proc 2nd Meeting of ISAO, 1979, p 203Google Scholar
  253. 253.
    Kambic H, Barenburg S, Harasaki H, Gibbons D, Kiraly R, Nose Y; Glutaraldehyde-protein complexes as blood compatible coatings. Trans Am Soc Artif Intern Organs 24: 426, 1978PubMedGoogle Scholar
  254. 254.
    Mansfield PB, Wechezak AR, Sauvage LR: Preventing thrombus on artificial vascular surfaces: true endothelial cell linings. Trans Am Soc Artif Intern Organs 21: 264, 1975PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • S. Fazal Mohammad

There are no affiliations available

Personalised recommendations